Literature DB >> 2060523

An overview of the problem of toxoplasmosis and pneumocystosis in AIDS in the USA: implication for future therapeutic trials.

B J Luft1, K G Castro.   

Abstract

By the end of 1989, 18,518 cases of Pneumocystis carinii infection and 5,614 cases of Toxoplasma gondii infection were reported to the Centers for Disease Control as the AIDS indicator disease. Pneumocystosis did not vary according to gender, race or risk factors; whereas toxoplasmosis was more common in black males with no known risk factors. Immigrants to the USA from Africa, Latin America and Haiti are three to four times more likely to develop toxoplasmic encephalitis than American-born patients with AIDS. The implications of this epidemiologic data for the predictive value of serology and clinical trials are discussed.

Entities:  

Mesh:

Year:  1991        PMID: 2060523     DOI: 10.1007/bf01964455

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  4 in total

Review 1.  Special considerations for managing suspected human immunodeficiency virus infection and AIDS in patients from developing countries.

Authors:  J K Kreiss; K G Castro
Journal:  J Infect Dis       Date:  1990-10       Impact factor: 5.226

2.  Evaluation of the policy of empiric treatment of suspected Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome.

Authors:  J A Cohn; A McMeeking; W Cohen; J Jacobs; R S Holzman
Journal:  Am J Med       Date:  1989-05       Impact factor: 4.965

3.  Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS.

Authors:  I H Grant; J W Gold; M Rosenblum; D Niedzwiecki; D Armstrong
Journal:  AIDS       Date:  1990-06       Impact factor: 4.177

4.  Brain lesions in patients with acquired immunodeficiency syndrome.

Authors:  E Bishburg; R H Eng; J Slim; G Perez; E Johnson
Journal:  Arch Intern Med       Date:  1989-04
  4 in total
  7 in total

Review 1.  The development and biology of bradyzoites of Toxoplasma gondii.

Authors:  L M Weiss; K Kim
Journal:  Front Biosci       Date:  2000-04-01

2.  Toxoplasmic encephalitis in AIDS-patients before and after the introduction of highly active antiretroviral therapy (HAART).

Authors:  T R Kiderlen; O Liesenfeld; D Schürmann; T Schneider
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-04-15       Impact factor: 3.267

3.  Toxoplasma: Immunity and Pathogenesis.

Authors:  Imtiaz A Khan; Charlotte Ouellette; Keer Chen; Magali Moretto
Journal:  Curr Clin Microbiol Rep       Date:  2019-02-04

4.  Expression of herpes simplex virus thymidine kinase in Toxoplasma gondii attenuates tachyzoite virulence in mice.

Authors:  J R Radke; M W White
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

5.  Protective vaccination with promastigote surface antigen 2 from Leishmania major is mediated by a TH1 type of immune response.

Authors:  E Handman; F M Symons; T M Baldwin; J M Curtis; J P Scheerlinck
Journal:  Infect Immun       Date:  1995-11       Impact factor: 3.441

6.  Persistence of virulent Leishmania major in murine cutaneous leishmaniasis: a possible hazard for the host.

Authors:  T Aebischer; S F Moody; E Handman
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

7.  Downregulated IL-21 Response and T Follicular Helper Cell Exhaustion Correlate with Compromised CD8 T Cell Immunity during Chronic Toxoplasmosis.

Authors:  Magali M Moretto; SuJin Hwang; Imtiaz A Khan
Journal:  Front Immunol       Date:  2017-10-31       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.